Is Ovarian Cancer Genetic?

How Genetic Is Ovarian Cancer?

Ovarian Cancer has a strong genetic basis. Research estimates heritability at approximately 39%, meaning genetic factors account for the majority of variation in whether individuals develop this condition.

Key genes associated with Ovarian Cancer: BRCA1,BRCA2,RAD51C,RAD51D. Variants in these genes have been identified through genome-wide association studies (GWAS) and clinical research as influencing susceptibility or severity.

Source: MedlinePlus Genetics

Does Family History Matter for Ovarian Cancer?

Yes — family history is one of the strongest predictors of Ovarian Cancer. If a first-degree relative (parent, sibling, or child) has been diagnosed, your own risk may be significantly elevated. Discussing your family history with a healthcare provider or genetic counsellor is strongly recommended.

How Is Ovarian Cancer's Genetic Risk Different From Breast Cancer's?

Ovarian cancer shares its best-known hereditary cause with breast cancer — inherited BRCA1 or BRCA2 mutations — and the CDC puts hereditary ovarian cancer at a broadly similar scale to hereditary breast cancer: roughly 10-15% of ovarian cancer cases are hereditary. But the actual numbers aren't identical. Per the National Cancer Institute, women who inherit a harmful BRCA1 variant face roughly a 39-58% lifetime risk of ovarian cancer, and BRCA2 carriers roughly 13-29% — both real, cancer-specific figures, not the same percentages BRCA1/BRCA2 carry for breast cancer risk. Two more genes, RAD51C and RAD51D, are separately established moderate-penetrance ovarian cancer risk genes that don't feature in this site's breast cancer coverage at all.

The most practically important difference, though, isn't a statistic — it's the absence of one. Unlike breast cancer, which has an established population screening tool (mammography), there is no reliable general-population screening test for ovarian cancer: CA-125 blood tests and transvaginal ultrasound haven't been shown to catch it early enough, or reduce deaths, when used to screen women at average risk. That gap is exactly why, for someone with a confirmed high-risk mutation, the conversation more often moves directly to risk-reducing surgery (bilateral salpingo-oophorectomy) rather than routine screening — research cited by Healthline suggests this can reduce ovarian and fallopian tube cancer risk by roughly 80% in mutation carriers who choose it.

Sources: CDC — What Causes Hereditary Breast and Ovarian Cancer, NCI — BRCA Gene Changes: Cancer Risk and Genetic Testing Fact Sheet, Healthline — Is Ovarian Cancer Genetic?

Is Genetic Testing for Ovarian Cancer Worth It?

Much of the clinical testing pathway here is the same one already covered on this site's breast cancer page — BRCA1/BRCA2 (and, for ovarian cancer specifically, RAD51C/RAD51D) testing ordered through a doctor or genetic counsellor, not a home DNA panel. What's genuinely different is what a positive result tends to lead to: because there's no reliable general-population ovarian screening test, a confirmed high-risk mutation more directly changes the decision between intensive specialist surveillance and risk-reducing surgery, rather than simply prompting more frequent monitoring.

A consumer DNA panel like CircleDNA is not a substitute for clinical BRCA/RAD51C/RAD51D testing or genetic counselling. Because the underlying genetics substantially overlap with breast cancer's, mapping out which relatives have had breast or ovarian cancer, and at what age, is a genuinely useful starting point either way. Our Family History Risk Checker walks through a few questions about affected relatives and returns a plain-language read on your own inherited risk — an interactive step neither the CDC's, NCI's, nor Healthline's ovarian cancer genetics pages embed directly.

Related Genetic Conditions

• Is Birt-Hogg-Dubé Syndrome genetic?
• Is Breast Cancer genetic?
• Is Cowden Syndrome genetic?
• Is Familial Adenomatous Polyposis genetic?
• Is Gorlin Syndrome genetic?